...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The American Journal of Cardiology >Coronary Artery Disease Performance Measures and Statin Use in Patients With Recent Percutaneous Coronary Intervention or Recent Coronary Artery Bypass Grafting (from the NCDR PINNACLE Registry)
【24h】

Coronary Artery Disease Performance Measures and Statin Use in Patients With Recent Percutaneous Coronary Intervention or Recent Coronary Artery Bypass Grafting (from the NCDR PINNACLE Registry)

机译：近期经皮冠状动脉介入治疗或近期冠状动脉旁路移植术患者的冠状动脉疾病表现测量和他汀类药物的使用（来自NCDR PINNACLE注册中心）

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The association between coronary revascularization strategy (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) and compliance with coronary artery disease (CAD) performance measures is not well studied. Our analysis studied patients enrolled in the Practice Innovation and Clinical Excellence registry, who underwent coronary revascularization using PCI or CABG in the 12 months before their most recent outpatient visit in 2011. We compared the attainment of CAD performance measures and statin use in eligible patients with PCI and CABG using hierarchical logistic regression models. Our study cohort consisted of 112,969 patients (80,753 with PCI and 32,216 with CABG). After adjustment for site and patient characteristics, performance measure compliance for tobacco use query (odds ratio [OR] 0.80; 95% confidence interval [CI] 0.76 to 0.86), antiplatelet therapy (OR 0.9; 95% CI 0.86 to 0.94) and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy (OR 0.89; 95% CI 0.84 to 0.94) was lower in CABG compared with patients with PCI. Patients who underwent recent CABG had higher rates of beta-blocker (OR 1.25; 95% CI 1.16 to 1.33) and statin treatment (OR 1.37; 95% CI 1.31 to 1.43) compared with patients with PCI. Of the 79 practice sites, 15 (19%) had 75% of their patients with CAD (CABG or PCI) meeting 75% to 100% of all eligible CAD performance measures. In conclusion, gaps persist in compliance with specific CAD performance measures in patients with recent PCI or CABG, and 1 in 5 practices had 75% compliance of eligible CAD performance measures in the most of their patients. (C) 2015 Elsevier Inc. All rights reserved.
机译：冠状动脉血运重建策略（经皮冠状动脉介入治疗[PCI]或冠状动脉搭桥术[CABG]）与遵守冠状动脉疾病（CAD）性能指标之间的关联尚未得到很好的研究。我们的分析研究了登记在“实践创新和卓越临床实践”注册表中的患者，这些患者在2011年最近一次门诊之前的12个月内使用PCI或CABG进行了冠脉血运重建。 PCI和CABG使用分层逻辑回归模型。我们的研究队列包括112,969名患者（80,753名PCI患者和32,216名CABG患者）。在调整了场所和患者特征后，对烟草使用查询（赔率比[OR] 0.80; 95％置信区间[CI] 0.76至0.86），抗血小板治疗（OR 0.9; 95％CI 0.86至0.94）和血管紧张素进行了性能评估与PCI患者相比，CABG中的转化酶抑制剂/血管紧张素受体阻滞剂治疗（OR 0.89; 95％CI 0.84至0.94）更低。与PCI患者相比，最近接受CABG治疗的患者具有更高的β受体阻滞剂（OR 1.25; 95％CI 1.16至1.33）和他汀类药物治疗（OR 1.37; 95％CI 1.31至1.43）。在79个实践场所中，有15个（19％）的CAD（CABG或PCI）患者达到了所有合格CAD绩效指标的75％至100％。总之，在近期有PCI或CABG的患者中，在遵守特定的CAD表现指标方面仍然存在差距，并且五分之一的实践表明，大多数患者中有75％符合合格的CAD表现指标。 （C）2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号